Stivarga 40 MG tablet 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FSCC3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,715
Award facts
- Contract value 100% obligated
- $15,714.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,714.63 to DMS Pharmaceutical Group Inc. for STIVARGA 40 mg tablets (21-count units) with a firm fixed-price structure. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is set to be completed by December 23, 2025, and will be performed at the contractor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499,999,999 ceiling value extending through December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. As an established prime vendor contractor under this framework, DMS Pharmaceutical Group supplies a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide, with this particular delivery order supporting recurring medical supply needs for oncology and related therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FSCC3?
SPE2DR26FSCC3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FSCC3 worth?
The government has obligated $15,715 on SPE2DR26FSCC3.
Is contract SPE2DR26FSCC3 an order under another contract?
Yes. SPE2DR26FSCC3 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCC3 competed?
The extent of competition for SPE2DR26FSCC3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award